Literature DB >> 6833498

Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism.

T J Visser, M M Kaplan, J L Leonard, P R Larsen.   

Abstract

We have studied 5'-deiodination of thyroxine (T(4)) and 3,3',5'-triiodothyronine (rT(3)) in rat pituitary tissue in vitro, with respect to substrate specificity, reaction kinetics, effects of 6-n-propyl-2-thiouracil (PTU), and the time course of effects of thyroid hormone depletion and repletion. Removal of one phenolic iodine or both tyrosyl iodines from the T(4) molecule resulted in compounds that were not deiodinated, but alterations in the alanine side chain had little effect.5'-Deiodination of 2 nM rT(3) by pituitary microsomes from euthyroid rats was inhibited >90% by 1 mM PTU, but was inhibited <10% by 100 nM T(4). The apparent Michaelis constant (K(m)) and maximum velocity (V(max)) for rT(3) at 20 mM dithiothreitol (DTT) were 33 nM and 84 pmol/mg protein per h. This reaction followed ping-pong type reaction kinetics when concentrations of DTT were varied. PTU inhibition was competitive with DTT and uncompetitive with rT(3). In contrast, when pituitary microsomes from hypothyroid rats (21 d postthyroidectomy) were used, deiodination of 2 nM rT(3) was inhibited only 20% by 1 mM PTU and up to 80% by 100 nM T(4). At 20 mM DTT, the apparent K(m) and V(max) in hypothyroid microsomes were 4.7 nM rT(3) and 16 pmol/mg protein per h. T(4) was a competitive inhibitor of PTU-insensitive rT(3) 5'-deiodination (K(i) = 1.3 nM). T(4) 5'-deiodination by hypothyroid microsomes was not affected by PTU, was competitively inhibited by rT(3) (K(i), 1.7 nM), and exhibited sequential type reaction kinetics with DTT as cosubstrate. When T(4) 5'-deiodination was measured in euthyroid and hypothyroid microsomes, respectively, the apparent K(m) and V(max) for T(4) at 20 mM DTT, were 0.9 nM and 0.55 pmol/mg protein per h (euthyroid), and 0.8 nM and 6.9 pmol/mg protein per h (hypothyroid). The T(4) 5'-deiodination rate and the PTU-insensitive, but not total, rT(3) 5'-deiodination rate (i.e. measured in the presence and the absence of 1 mM PTU, respectively) in pituitary homogenates were significantly elevated 24 h after thyroidectomy. PTU-insensitive activity continued to increase until at >/=30 d after thyroidectomy it was 11 times the PTU-insensitive activity in controls. At the latter time, PTU-sensitive rT(3) 5'-deiodinase activity appeared to be decreased. The increase in PTU-insensitive T(4) and rT(3) 5'-deiodination observed 48 h after thyroidectomy was prevented by replacement doses of T(4) or T(3). The PTU-insensitive activity of long term hypothyroid pituitaries was decreased by 71% and >/=84% 4 h after injection of 20 and 200 mug T(3), respectively, with no change in PTU-sensitive rT(3) deiodination. These data show that rat pituitary tissue contains two distinct iodothyronine 5'-deiodinating pathways that differ with respect to substrate specificity, PTU sensitivity, reaction kinetics, and regulation by thyroid hormone. One of these resembles the 5'-deiodinase of liver and kidney, and predominates in euthyroid pituitary tissue in vitro. The other, also found in rat brain, predominates in hypothyroid pituitary tissue, is rapidly responsive to changes in thyroid hormone availability, and, as judged by previous, in vivo studies, appears to account for all the T(3) produced locally in the pituitary and, thereby, 50% of the intracellular T(3) in this tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833498      PMCID: PMC436957          DOI: 10.1172/jci110854

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Conversion of thyroxine into tri-iodothyronine by rat liver homogenate.

Authors: 
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

2.  Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.

Authors:  J E Silva; T E Dick; P R Larsen
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

6.  Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay.

Authors:  J Weeke; H Orskov
Journal:  Scand J Clin Lab Invest       Date:  1973-12       Impact factor: 1.713

7.  Thyroxine to 3,5,3'-triiodothyronine conversion by rat anterior pituitary and liver.

Authors:  J E Silva; M M Kaplan; R G Cheron; T E Dick; P R Larsen
Journal:  Metabolism       Date:  1978-11       Impact factor: 8.694

8.  Iodothyronine metabolism in liver and kidney homogenates from hyperthyroid and hypothyroid rats.

Authors:  M M Kaplan; R D Utiger
Journal:  Endocrinology       Date:  1978-07       Impact factor: 4.736

9.  Peripheral metabolism of homologous thyrotropin in euthyroid and hypothyroid rats: acute effects of thyrotropin-releasing hormone, triiodothyronine, and thyroxine.

Authors:  J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1978-06       Impact factor: 4.736

10.  Triiodothyronine stimulates specifically growth hormone mRNA in rat pituitary tumor cells.

Authors:  H Seo; G Vassart; H Brocas; S Refetoff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

View more
  32 in total

Review 1.  Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options.

Authors:  Satoru Suzuki; Satoshi Shigematsu; Hidefumi Inaba; Masahiro Takei; Teiji Takeda; Mitsuhisa Komatsu
Journal:  Endocrine       Date:  2011-09-29       Impact factor: 3.633

2.  The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.

Authors:  Francesco S Celi; Giuseppe Coppotelli; Aaron Chidakel; Marilyn Kelly; Beth A Brillante; Thomas Shawker; Natasha Cherman; Penelope P Feuillan; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

3.  An AOP-based alternative testing strategy to predict the impact of thyroid hormone disruption on swim bladder inflation in zebrafish.

Authors:  Evelyn Stinckens; Lucia Vergauwen; Gerald T Ankley; Ronny Blust; Veerle M Darras; Daniel L Villeneuve; Hilda Witters; David C Volz; Dries Knapen
Journal:  Aquat Toxicol       Date:  2018-04-21       Impact factor: 4.964

4.  Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes.

Authors:  J Steinsapir; J Harney; P R Larsen
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

5.  Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats.

Authors:  D L St Germain; V A Galton
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Iodothyronine 5'-deiodinase activity as an early event of prenatal brown-fat differentiation in bovine development.

Authors:  M Giralt; L Casteilla; O Viñas; T Mampel; R Iglesias; J Robelin; F Villarroya
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

7.  Type 2 iodothyronine deiodinase is highly expressed in human thyroid.

Authors:  D Salvatore; H Tu; J W Harney; P R Larsen
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

8.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

9.  Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats.

Authors:  J E Silva; M B Gordon; F R Crantz; J L Leonard; P R Larsen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Rapid alteration in circulating free thyroxine modulates pituitary type II 5' deiodinase and basal thyrotropin secretion in the rat.

Authors:  S L Abend; S L Fang; S Alex; L E Braverman; J L Leonard
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.